The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.
about
Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2Simian homologues of Epstein-Barr virusHodgkin's disease and the Epstein-Barr virus.BS69, a specific adaptor in the latent membrane protein 1-mediated c-Jun N-terminal kinase pathwayThe Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activationTumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming proteinThe Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaBThe oncogenic protein kinase Tpl-2/Cot contributes to Epstein-Barr virus-encoded latent infection membrane protein 1-induced NF-kappaB signaling downstream of TRAF2Latent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-kappaB signaling pathwayActivation of mitogen-activated protein kinase and NF-kappaB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane proteinThe viral etiology of AIDS-associated malignanciesLipoxins: nature's way to resolve inflammationThe criteria to confirm the role of Epstein-Barr virus in nasopharyngeal carcinoma initiationEpstein-Barr virus and the origin of Hodgkin lymphomaEpstein-barr virus sequence variation-biology and diseaseSalicylates inhibit flavivirus replication independently of blocking nuclear factor kappa B activation.Latent Membrane Protein 1 as a molecular adjuvant for single-cycle lentiviral vaccinesTRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1Lupeol is one of active components in the extract of Chrysanthemum indicum Linne that inhibits LMP1-induced NF-κB activationModulation of NF-κB signalling by microbial pathogensNewly emerging therapies targeting viral-related lymphomas.Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expressionInteraction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expressionThe role of viral and bacterial pathogens in gastrointestinal cancer.Hairy leukoplakia: an unusual combination of transforming and permissive Epstein-Barr virus infections.Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.Signaling activities of gammaherpesvirus membrane proteinsAn Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformationInterferon regulatory factor 7 mediates activation of Tap-2 by Epstein-Barr virus latent membrane protein 1.Mutations in the Epstein-Barr virus latent membrane protein-1 (BNLF-1) gene in spontaneous lymphoblastoid cell lines: effect on in vitro transformation associated parameters and tumorigenicity in SCID and nude miceIntracellular signaling molecules activated by Epstein-Barr virus for induction of interferon regulatory factor 7.The Epstein-Barr virus and its association with human cancers.Epstein-Barr virus (EBV)-associated epithelial and non-epithelial lesions of the oral cavity.Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategiesEpstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade.Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptorLMP1 signal transduction differs substantially from TNF receptor 1 signaling in the molecular functions of TRADD and TRAF2Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteinsLatent membrane protein 1 is dispensable for Epstein-Barr virus replication in human embryonic kidney 293 cells.The expression and function of Epstein-Barr virus encoded latent genes
P2860
Q24516975-C7AF75FB-64CB-4D95-9916-4E34021300CCQ24522326-6D5C4E1D-661B-402C-8061-13409F2A65E1Q24535291-583CA32C-2ACD-43AE-B7B6-52B8AD24B38CQ24537608-ED9B1CE1-1235-4A27-9E8E-36A84BAADE1FQ24554457-940E3B16-D508-49A4-9252-5CCFA762513DQ24599252-279C23CA-BD75-41E4-8246-2A99DBCE258EQ24646694-6E766598-5CAC-42DF-8CD5-E0AA75CC60F7Q24674848-E6CF88A6-F15F-44A0-9194-AB5D422D12F0Q24682515-0B0A5F02-E164-40CE-A9EE-36AF59321B81Q24683297-014A9432-8F98-41A4-B809-61E385B7339EQ24685892-13EC703B-DD99-49E9-B597-85C96D8BC5B8Q26784376-E9A9F2BB-412B-447E-9C46-9C988E4BADE4Q26853527-F2ECC4A5-B189-430F-A2B7-1240878F8A89Q26998999-2527164C-B007-4837-9848-4E4E1BECDECFQ27003183-E843BDA9-164C-4F8E-8FBA-6DC53A2645DDQ27469944-9BBAAEC7-FB6E-4B37-8ACD-50F67C3CDA3DQ27497985-01C74EF4-8C2C-4BAE-9637-25A589784009Q28361340-A599B64E-BF6C-4971-BC04-C4C90913F887Q28535439-409C747C-4F8E-48D5-A9F6-C3073307F98AQ28709497-E71B8177-84E0-41AC-87F9-F24B65C7E813Q33699201-935A6B76-EEB4-4A67-BE78-CD26D1F7D7FEQ33784729-DCB0AD13-8621-465C-A352-78CBEC0E1D37Q33786551-C70C4990-0FA0-4254-9CD8-DC4B198C8410Q33791751-2DF0B043-D3BC-4A60-A776-D8A06D0F5A23Q33809963-E013E4E8-1BC0-4F9E-AD17-31656A4F1FE3Q33815241-9F054E07-C33C-4C93-8B70-11A5E62A25FBQ33822504-61CC4E44-01CF-447F-B433-84B425CBFEB9Q33825713-B7416BA8-DB34-4E8C-B650-868395D0B506Q33834888-83515B60-545E-4BE3-BF92-912165CAFBD5Q33841899-DF50A7B4-DDF8-4AEF-93C2-B9A52854E3CBQ33870488-D47F0EF4-5A6B-4292-92C2-49BB9C67F4EBQ33882153-12E29E01-1F80-4C0F-A6E1-4DD3FFC9A145Q33884691-27B50903-D689-4EE4-8BEE-3EA04F9CB049Q33886267-35E6D6DF-6ACF-43F3-9932-3ECD29A87037Q33887684-4A4AD798-83C6-478E-BADF-0A35D9F613E8Q33888498-1247AEC4-BD11-417F-9B11-0D26EEFD6FD1Q33890869-92C488E8-8D26-4724-8FAE-2C2AA7DEB8EDQ33891012-2D06E53B-A5C2-46D1-83F3-7F8F10C781B4Q33996858-E676B355-AE25-4E15-813E-3EAF425A8304Q34089485-DFDE9DF4-4A7F-4874-81B5-43D2EDD05CAA
P2860
The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
The Epstein-Barr virus latent ...... y-terminal cytoplasmic domain.
@en
type
label
The Epstein-Barr virus latent ...... y-terminal cytoplasmic domain.
@en
prefLabel
The Epstein-Barr virus latent ...... y-terminal cytoplasmic domain.
@en
P2093
P1433
P1476
The Epstein-Barr virus latent ...... xy-terminal cytoplasmic domain
@en
P2093
Croom-Carter D
Henderson SA
P304
P407
P577
1995-02-01T00:00:00Z